pET51b(+)_EGFP_NbALFA Citations (3)
Originally described in: Chemogenetic Control of Nanobodies.Farrants H, Tarnawski M, Muller TG, Otsuka S, Hiblot J, Koch B, Kueblbeck M, Krausslich HG, Ellenberg J, Johnsson K Nat Methods. 2020 Feb 17. pii: 10.1038/s41592-020-0746-7. doi: 10.1038/s41592-020-0746-7. PubMed Journal
Articles Citing pET51b(+)_EGFP_NbALFA
| Articles |
|---|
Single-domain near-infrared protein provides a scaffold for antigen-dependent fluorescent nanobodies.
Oliinyk OS, Baloban M, Clark CL, Carey E, Pletnev S, Nimmerjahn A, Verkhusha VV.
Nat Methods. 2022 May 23. pii: 10.1038/s41592-022-01467-6. doi: 10.1038/s41592-022-01467-6.
PubMed
Associated Plasmids |
| The potential of ALFA-tag and tyramide-based fluorescence signal amplification to expand the CRISPR-based DNA imaging toolkit. Potlapalli BP, Fuchs J, Rutten T, Meister A, Houben A. J Exp Bot. 2024 Oct 30;75(20):6244-6257. doi: 10.1093/jxb/erae341. PubMed |
| Functional Blood-Brain Barrier Crossing by Biomimetic M13 Phage Vectors for Targeted Neuronal Delivery. Vercellino S, Pappagallo L, De Chirico F, Boselli L, Ahmed H, Spagnoletti L, Pittaluga G, Costantini PE, Calvaresi M, Pompa PP, Danielli A, Benfenati F, Castagnola V. Adv Healthc Mater. 2026 May 29:e00029. doi: 10.1002/adhm.202600029. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.